AI Thinks It Can Out-Code Cancer. Human Biology Says Not So Fast.
4 Articles
4 Articles
While Anthropic has signaled innovation in the life sciences, including new drug development, through its NASDAQ listing, the academic community maintains a cautious stance, pointing out insufficient verification of research achievements. In particular, concerns are continuously being raised both within and outside academia regarding the possibility that Anthropic's long-held AI safety policies could be weakened due to profit pressure following …
AI Thinks It Can Out-Code Cancer. Human Biology Says Not So Fast.
(WSJ) – Ahead of Anthropic’s initial public offering this week, Amodei doubled down on his view that AI could make diseases such as cancer and Alzheimer’s relics of the past within a decade. It is a breathtaking promise, and at least a part of the story behind Anthropic’s $1.3 trillion valuation. The company isn’t just selling a better chatbot or a faster coding assistant. It’s selling the prospect of transforming enormous industries. Yet the p…
Anthropic faces questions about how to balance his business ambitions with his emphasis on AI security.
A statement published on November 18 brings together security researchers, advocates of open models, mathematicians and technological entrepreneurs. The signatories accuse Anthropic The post Scientists, Nobel laureates and AI referents question the safety of Anthropic on the eve of its stock market debut appeared first on .
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium







